Vascular Medicine,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 24, 2025
Introduction:
Exercise
transcutaneous
oximetry
(Ex-TcpO2)
is
used
to
support
the
vascular
origin
of
lower-limb
pain,
or
assess
walking
impairment.
The
aim
this
study
was
describe
association
between
Ex-TcpO2
measurement
and
perioperative
clinical
morphological
outcomes
after
revascularization
in
patients
with
intermittent
claudication
(IC).
Methods:
From
January
December
2022,
a
single-center
prospective
observational
conducted
among
IC.
Patients
were
referred
by
surgeons
for
doubtful
arterial
origin.
Perioperative
assessed
Rutherford–Becker
classification
duplex
ultrasound
examination.
primary
patency
rate
sustained
improvement
evaluated
at
1
month
revascularization.
Results:
Eighty-two
(64%
men)
underwent
enrolled
study,
whom
65%
category
III
Rutherford
classification.
Indications
IC
symptoms
65%.
Sixty-seven
(81%)
had
positive
Ex-TcpO2,
15
(18%)
negative
Ex-TcpO2.
older
(65
±
13
vs
58
20,
p
=
0.43),
significantly
lower
ankle–brachial
index
(ABI)
compared
group
(0.65
0.22
0.92
0.22,
<
0.001)
as
well
maximum
distance
(MWD)
(200
m
[150,
300]
525
[500,
872],
0.001).
Forty-two
(Ex-TcpO2
[
n
35/67];
7/15]).
Revascularization
technical
success
100%
both
groups.
Clinical
greater
(97%
34/35]
0%
0/7],
Multivariate
analysis
shows
pain
buttock
decrease
from
rest
oxygen
pressure
(DROP)
≤
–15
mmHg
level
presence
iliac
lesions.
Conclusion:
On
routine
basis,
tool
interest
distance,
especially
proximal
IC,
predict
favorable
Pharmaceuticals,
Год журнала:
2025,
Номер
18(1), С. 60 - 60
Опубликована: Янв. 7, 2025
Objective:
Peripheral
artery
disease
(PAD)
is
a
prevalent
vascular
condition
characterized
by
arterial
narrowing,
which
impairs
blood
flow
and
manifests
as
intermittent
claudication,
pain
or
cramping
sensation
induced
physical
activity
ambulation.
Walking
distance
crucial
clinical
indicator
of
peripheral
disease,
it
correlates
with
the
severity
risk
mortality.
It
reflects
reduced
mobility
indicating
an
increased
morbidity.
can
also
inform
on
efficacy
treatment.
Cilostazol,
phosphodiesterase
III
inhibitor,
has
been
demonstrated
to
enhance
walking
in
patients
through
dilation
vessels
inhibition
platelet
aggregation.
With
this
preliminary
study,
we
aimed
elucidate
other
possible
effects
cilostazol,
specifically
its
influence
structural
properties
red
cells.
Methods:
10
(5
men,
5
women)
PAD
were
treated
cilostazol
over
three-month
period.
Its
biochemical
RBCs
determined
using
differential
scanning
calorimetry
(DSC).
Patient's
samples
collected
at
start
treatment,
then
after
two
weeks,
one
month,
months,
three
months
therapy.
Results:
The
DSC
analysis
revealed
shifts
thermal
properties,
including
change
peak
(melting
denaturation)
temperature
(Tp)
calorimetric
enthalpy
(ΔHcal),
indicate
significant
changes
These
property
correlated
improvements
reported
patients.
Conclusions:
Our
findings
suggest
that
induces
substantial
modifications
cells,
enhancing
their
functional
contributing
improved
outcomes.
This
study
highlights
potential
adjunctive
method
for
assessing
effectiveness
treatments
cellular
level.
However,
further
investigation
larger
patient
cohorts
required
confirm
these
initial
results.
Background:
Lower
extremity
peripheral
artery
disease
(PAD)
is
caused
by
atherosclerosis,
which
impacts
the
arteries
responsible
for
supplying
blood
to
lower
extremities.
In
patients
with
PAD,
vessel
lumen
becomes
narrow,
resulting
in
flow
limitations,
thrombosis,
and
a
range
of
complications.
At
present,
recognition
PAD
still
at
relatively
low
level.
this
study,
we
utilized
data
from
Global
Burden
Disease
Study
Database
spanning
1990
2021
compute
various
metrics,
including
incidence,
prevalence,
mortality,
disability-adjusted
life
years,
attributable
risk
factors,
estimate
annual
percentage
changes
(EAPC).
The
EAPC
serves
as
metric
evaluating
temporal
trends.Methods:
analysis
was
stratified
age,
sex,
sociodemographic
index
(SDI),
geographic
region.
Joinpoint
regression
employed
examine
trends
age-standardized
incidence
rates
(ASIRs),
prevalence
rates,
mortality
year
both
globally
across
five
distinct
SDI
regions.Findings:
on
rise
regions.
ASIR
increasing
some
High
fasting
plasma
glucose
emerged
most
significant
factor
contributing
burden.
expected
stabilize
2045
after
minor
increase.Interpretation:
A
better
understanding
can
facilitate
development
targeted
response
measures
healthcare
policies.
Additionally,
projected
burden
enable
timely
interventions
reducing
impact
disease.Funding:
This
study
did
not
receive
any
funding.Declaration
Interest:
authors
declare
that
they
have
no
known
competing
financial
interests
or
personal
relationships
could
appeared
influence
work
reported
article.Ethical
Approval:
received
an
exemption
Institutional
Review
Board
(IRB)
it
publicly
accessible
contain
confidential
personally
identifiable
information.
Journal of Zhejiang University (Medical Sciences),
Год журнала:
2025,
Номер
54(1), С. 10 - 20
Опубликована: Янв. 1, 2025
To
analyze
the
disease
burden
and
inequalities
of
lower
extremity
peripheral
artery
disorders
(LEPAD)
among
people
aged
40
above
in
Belt
Road
partner
countries
from
1990
to
2021.
Data
were
retrieved
Global
Burden
Disease
2021
database.
The
age-standardized
prevalence
rates,
mortality
annual
rate
years
lived
with
disability
(YLDs)
LEPAD
analyzed.
Trends
measured
using
estimated
percentage
change
(EAPC),
slope
index
inequality
(SII)
concentration
used
quantify
absolute
relative
inequalities.
In
2021,
rates
3168.26/105
3.09/105,
increasing
by
4.30%
19.31%
compared
1990,
YLDs
decreased
4.00%.
Females
had
higher
while
males
rates.
EAPC
for
was
slightly
(0.22%)
than
females
(0.17%);
2.02%
females,
1.45%
males.
From
16.23/105
15.58/105,
a
faster
decline
(-0.12%)
(-0.06%).
varied
across
countries,
burdens
Europe
growth
Gulf
states.
Higher
socio-demographic
prevalence.
Inequity
improved,
SII
at
52.90/105
0.038
Gender
disparities
persisted,
rising
0.058
falling
-0.026
risen,
Significant
differences
exist
peoples
different
gender
highlighting
need
enhanced
screening,
health
education,
shared
public
strategies
countries.
Seminars in Vascular Surgery,
Год журнала:
2025,
Номер
38(1), С. 54 - 63
Опубликована: Янв. 18, 2025
The
initial
skin
breakdown
and
subsequent
healing
processes
are
complex
influenced
by
various
parameters,
including
systemic
factors,
infectious
bioburden,
perfusion.
Vascular
wounds
comprise
inadequate
inflow
(due
to
peripheral
artery
disease),
microvascular
damage
(result
of
diabetes
mellitus),
or
vasoconstriction.
Normal
acute
occurs
in
a
sequence
defined
stages;
however,
if
dysregulated
inflammatory
state
ensues,
it
is
classified
as
chronic.
Both
chronic
vascular
carry
an
increased
risk
amputation.
Therefore,
holistic
wound
care
crucial
preventing
limb
loss.
This
review
outlines
systematic
approach
assessment
examines
the
latest
recommendations
for
managing
wounds,
focusing
on
strategies
amputations.
BMJ Open,
Год журнала:
2025,
Номер
15(1), С. e093162 - e093162
Опубликована: Янв. 1, 2025
Introduction
Patients
with
peripheral
artery
disease
(PAD)
can
experience
intermittent
claudication,
which
limits
walking
capacity
and
the
ability
to
undertake
daily
activities.
While
exercise
therapy
is
an
established
way
improve
in
people
PAD,
it
not
feasible
all
patients.
Neuromuscular
electrical
stimulation
(NMES)
provides
a
passively
induce
repeated
muscle
contractions
has
been
widely
used
as
for
chronic
conditions
that
limit
functional
capacity.
Preliminary
trials
patients
PAD
demonstrate
of
leg
muscles
using
footplate-NMES
device
be
performed
without
pain
may
lead
significant
gains
Studies,
date,
have
small
adequately
controlled
account
any
potential
placebo
effect.
Therefore,
current
trial
will
compare
effect
12-week
programme
placebo-control
on
(6
min
distance)
other
secondary
outcomes
PAD.
Methods
analysis
The
Foot-PAD
double-blinded,
randomised
placebo-controlled
determine
home-based
footplate
NMES
This
single-centre
numerous
recruitment
locations.
A
total
180
participants
stable
claudication
randomly
assigned
(1:1
ratio)
receive
either
(intervention
condition)
or
footplate-placebo
(control
two
30
periods
each
day
12
weeks.
deliver
sufficient
contraction
plantar
dorsiflexion
at
ankles.
momentary
low-intensity
transient
insufficient
muscles.
Outcomes
assessed
baseline
(week
0),
mid-intervention
6),
postintervention
12)
6
weeks
after
completion
intervention
18).
primary
outcome
week
12,
measured
maximum
distance
during
walk
test.
Secondary
include
pain-free
test;
time
graded
treadmill
disease-specific
quality
life
(Intermittent
Claudication
Questionnaire),
self-reported
impairment
(Walking
Impairment
Questionnaire)
accelerometer-derived
physical
activity
levels.
Exploratory
Ankle-Brachial
Index;
vascular
function;
perception
device-use
symptom
monitoring
throughout
Symptom
Instrument
Visual
Analogue
Scale.
Ethics
dissemination
received
ethics
approval
from
Human
Research
Committees
Queensland
Health
Metro
North
Hospital
Service
(78962)
University
Sunshine
Coast
(A21659).
Regardless
study
outcomes,
findings
published
peer-reviewed
scientific
journals
presented
meetings.
Trial
registration
number
ACTRN12621001383853.
Journal of Endovascular Therapy,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 4, 2025
Objective:
This
updated
UK
multicenter
study
aims
to
report
long-term
results
following
use
of
the
Covered
Endovascular
Reconstruction
Aortic
Bifurcation
(CERAB)
technique
for
treating
aortoiliac
occlusive
disease
(AIOD)
in
patients
with
chronic
limb-threatening
ischemia
(CLTI)
or
intermittent
claudication
(IC).
Methods:
A
retrospective
analysis
was
conducted
including
85
who
underwent
CERAB
between
November
1,
2012,
and
March
31,
2020,
till
2024.
Anatomical
data
were
assessed
using
pre-operative
imaging.
Outcome
measures
included
freedom
from
target
lesion
reintervention
(fTLR),
major
limb
amputation
(fMLA),
overall
survival.
Results:
The
median
age
65
years,
62.4%
males.
Over
a
follow-up
58.2
months
(IQR
55.7–67.1
months),
2
lost
follow-up.
There
16
deaths
(18.8%)
amputations
(2.4%)
entire
period.
Target
required
14
(16.5%)
at
last
Kaplan-Meier
fTLR
3,
5
years
89.2%,
83.0%,
respectively.
fMLA
98%
all
intervals,
survival
rates
94.1%,
89.4%,
80.1%,
Subintimal
iliac
access
associated
worse
(HR
4.33
(95%
CI
1.30–14.37,
p=0.017)),
which
remained
significant
when
adjusted
patient
anatomical
characteristics
5.88
1.02–33.95,
p=0.047)).
no
association
need
common
femoral
endarterectomy
3.57
0.42–30.5,
p=0.244)]
external
artery
stenting
0.47
0.07–3.05,
p=0.427))
during
index
procedure.
Conclusion:
outcomes
AIOD
demonstrate
its
viability
as
durable
revascularization
option,
acceptable
morbidity,
mortality,
patency
rates.
Factors
reflecting
more
complex
lesions
are
poorer
outcomes.
Findings
support
randomized
controlled
trials
on
focus
pre-
intra-operative
decision-making
based
complexity
TASC
C
D
lesions.
Clinical
Impact
findings
this
reinforce
durability
(AIOD),
demonstrating
favourable
salvage
These
viable
alternative
open
surgery,
particularly
anatomies
comorbidities.
enables
clinicians
make
informed
decisions
regarding
selection
procedural
strategies,
such
minimising
subintimal
improve
underscores
further
randomised
establish
CERAB’s
role
evidence-based
clinical
guidelines
management.
Journal of Patient-Reported Outcomes,
Год журнала:
2025,
Номер
9(1)
Опубликована: Фев. 7, 2025
Peripheral
artery
disease
(PAD)
negatively
affects
walking
performance,
health-related
quality
of
life
(HRQoL)
and
mental
health.
Exercise
training
is
recommended
as
a
first-line
treatment
for
PAD,
with
potential
impact
on
all
these
outcomes,
but
the
optimal
program
design
not
completely
ascertained.
The
aim
this
study
was
to
compare
arm-ergometry
(AEx)
treadmill
supervised
exercise
(TEx)
HRQoL
health
in
patients
PAD.
This
an
ancillary
ARMEX
trial,
single-center,
single-blinded,
parallel
group,
randomized
clinical
enrolling
symptomatic
PAD
referred
cardiovascular
rehabilitation
(CRP).
Participants
were
(1:1)
12-week
AEx
or
TEx,
along
core
components
CRP
(nutritional
psychological
support).
completed
short
form
36
Health
Survey
Hospital
Anxiety
Depression
scale
before
after
intervention.
Differences
between
groups
change
from
baseline
end
analyzed
using
ANCOVA,
adjusted
values,
Mann-Whitney
U
test.
Fifty-six
(66
±
8.4
years;
87.5%
male)
included:
(n
=
28)
TEx
28).
Physical
functioning,
role-physical,
bodily-pain,
general
health,
physical
component
summary
(PCS)
significantly
improved
group.
In
vitality,
social
role-emotional
PCS
improved.
Role-physical
more
no
between-group
differences
other
domains.
Changes
associated
changes
distances.
scores
both
groups,
without
differences.
improvement
self-reported
distance.
Both
protocols
highlighting
exercise-based
programs
important
strategies
population.
ISRCTN54908548
(retrospectively
registered).